Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Isotonic saline + ephedrine is a therapeutic combination protocol used for the management of hemodynamic stability during spinal anesthesia, particularly in parturients undergoing cesarean section. The protocol involves the intravenous administration of an isotonic saline solution (0.9% sodium chloride) as a 'coload'—delivered simultaneously with the induction of anesthesia—to expand intravascular volume and mitigate the vasodilatory effects of sympathetic blockade. This is supplemented by rescue boluses of ephedrine, a sympathomimetic amine that acts as a non-selective agonist at alpha- and beta-adrenergic receptors. By stimulating these receptors, ephedrine increases cardiac output and peripheral vascular resistance, effectively treating or preventing maternal hypotension. This specific combination was evaluated as the 'standard of care' control arm (Arm T) in a clinical trial conducted by University Tunis El Manar (NCT05434104) comparing standard coloading to ultrasound-guided fluid preloading in hypovolemic patients.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on isotonic saline + ephedrine.